<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 08/06/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 08/06/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Samuel Acosta</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">July 29, 1964 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>2900 UNIVERSITY SQUARE DR<br/>APT 24<br/>TAMPA, FL 33612-5554, US<br/><br/>Primary Home Phone:  813-847-6479<br/>Mobile Phone:  813-847-6479<br/>Email:  samuelacosta@hotmail.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">243063 2.16.840.1.113883.4.391.327187<br/>243063 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">01f28d43-7a65-42f0-b029-af74c84153c0 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">September 10, 2024, 17:24:45 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Rodger Rothenberger</td></tr><tr><td class="td_header_role_value internal_format">13305 N 56TH ST<br/>TAMPA, FL 33617-1161, US<br/><br/>Tel:  813-988-1101<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">21326906 2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From August 6, 2024, 11:00:00   to August 6, 2024, 11:20:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Rodger Rothenberger</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">13305 N 56TH ST<br/>TAMPA, FL 33617-1161, US<br/><br/>Tel:  813-988-1101<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">MARIA RAMOS<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2900 University Sq drive<br/>TAMPA, FL 33609, US<br/><br/>Tel:  813-846-8392<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Samuel Acosta<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  813-847-6479<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Assessments</a></li><li><a href="#id7">Plan Of Treatment</a></li><li><a href="#id8">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1"/><td>dexcom g6 device glucose monitor adhesive (uncoded)</td><td ID="reaction1">Unknown</td><td>Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>4 month</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Ventolin HFA CFC free 90 mcg/inh</td><td ID="instruction1">inhale 2 puffs by mouth 4 times a day for 30 days</td><td ID="medication1notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Unknown</td></tr><tr><td ID="medication2">Sildenafil Citrate 100 MG</td><td ID="instruction2">1 tablet as needed Orally Once a day for 30 days</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication3">oxyCODONE HCl 30 MG</td><td ID="instruction3">1 tablet Orally four times a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication4">Omeprazole 40 MG</td><td ID="instruction4">TAKE ONE CAPSULE BY MOUTH 30 MINUTES BEFORE MORNING MEAL EVERY DAY for 30</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication5">NovoLOG FlexPen 100 units/mL</td><td ID="instruction5">use sliding scale subcutaneously three times a day</td><td ID="medication5notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Unknown</td></tr><tr><td ID="medication6">Albuterol Sulfate (2.5 MG/3ML) 0.083%</td><td ID="instruction6">USE 3 ML VIA NEBULIZER EVERY 6 HOURS Inhalation every 6 hrs for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Cefdinir 300 MG</td><td ID="instruction7">1 capsule Orally twice a day for 10 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Nebulizer -</td><td ID="instruction8">as directed Inhaler as directed</td><td/><td>09/09/2021</td><td/><td>Unknown</td></tr><tr><td ID="medication9">Lisinopril 5 mg</td><td ID="instruction9">1 tab(s) orally once a day</td><td/><td>03/02/2010</td><td/><td>Unknown</td></tr><tr><td ID="medication10">Lantus 100 units/mL</td><td ID="instruction10">52 units one time in the morning subcutaneously Daily</td><td ID="medication10notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Unknown</td></tr><tr><td ID="medication11">Atorvastatin Calcium 40 MG</td><td ID="instruction11">1 tablet Orally Once a day for 90 days</td><td/><td>06/16/2022</td><td/><td>Unknown</td></tr><tr><td ID="medication12">Aspir-Low 81 MG</td><td ID="instruction12">1 tablet Orally Once a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication13">Gabapentin 100 MG</td><td ID="instruction13">1 capsule Orally Three times per day for 30 days</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication14">BD Ultra -Fine 111 Short Pen Needles</td><td ID="instruction14">1 Needle Dermally three times day for 30 days</td><td ID="medication14notes">*Reorder from Medispan for eRx and Interaction Alerts*</td><td>06/18/2012</td><td/><td>Unknown</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Temple Terrace</td><td>13305 N 56TH ST TAMPA, FL 33617-1161</td><td>08/06/2024</td><td>Rodger Rothenberger</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Type 2 diabetes mellitus with diabetic polyneuropathy E11.42 ; Long term (current) use of insulin Z79.4 ; Type 2 diabetes mellitus with other diabetic kidney complication E11.29 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.51 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Proteinuria, unspecified R80.9 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Coronary artery disease of native artery of native heart with stable angina pectoris I25.118 ; Hypercholesterolemia E78.00 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Simple chronic bronchitis J41.0 ; History of hepatitis C Z86.19 ; Primary osteoarthritis involving multiple joints M15.9 ; Chronic pain syndrome G89.4 ; OPIOID DEPENDENCE, CONTINUOUS F11.20 ; BPH loc w urin obs/LUTS N40.1 ; Drug-induced constipation K59.03 ; Morbid obesity E66.01 ; Right knee pain, unspecified chronicity M25.561 and BMI 37.0-37.9, adult Z68.37</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">08/06/2024</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td>Adjust therapy to improve A1C - follow-up to monitorA1C, GFR and urine proteins - CKD2 present as a complication of diabetes. Adjust therapy to improve A1C - follow-up to monitorA1C, GFR and urine proteins - CKD2 present as a complication of diabetes.</td><td/></tr><tr><td ID="ref2">08/06/2024</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy (ICD-10 - E11.42)</td><td/><td>Monitor neurologic signs and symptoms going forward- neuropathy present as a complication of diabetes</td><td/></tr><tr><td ID="ref3">08/06/2024</td><td>Long term (current) use of insulin (ICD-10 - Z79.4)</td><td/><td>Adjust therapy to improve A1C - follow-up to monitorA1C. Adjust therapy to improve A1C - follow-up to monitorA1C.</td><td/></tr><tr><td ID="ref4">08/06/2024</td><td>Type 2 diabetes mellitus with other diabetic kidney complication (ICD-10 - E11.29)</td><td/><td>follow-up to monitorA1C, GFR and urine proteins - proteinuria present as a complication of diabetes.</td><td/></tr><tr><td ID="ref5">08/06/2024</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (ICD-10 - E11.51)</td><td>Decreased peripheral pulses. No clinical symptoms. Monitoring.</td><td>Monitor vascular signs and symptoms going forward- PVD present as a complication of diabetes</td><td/></tr><tr><td ID="ref6">08/06/2024</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td/><td>In order to preserve renal function we need strict control of blood pressure - which should be less than 140/90 per JNC-8 guidelines; strict control of the LDL cholesterol which should be below 100, using statins if necessary. I encourage you to drink 50 ounces of fluids daily, and follow a low sodium diet. Avoid nephrotoxins (like NSAIDs). Monitor.</td><td/></tr><tr><td ID="ref7">08/06/2024</td><td>Proteinuria, unspecified (ICD-10 - R80.9)</td><td/><td>monitorA1C, GFR and urine proteins - proteinuria present as a complication of diabetes.</td><td/></tr><tr><td ID="ref8">08/06/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td/><td>Controlling your high blood pressure is a lifelong commitment.  You will always need to monitor your weight, make healthy food choices, exercise, learn to cope with stress, avoid smoking, and limit your alcohol intake.  We will monitor your blood pressure going forward.</td><td/></tr><tr><td ID="ref9">08/06/2024</td><td>Coronary artery disease of native artery of native heart with stable angina pectoris (ICD-10 - I25.118)</td><td/><td>Maintain good control of BP and Lipids, Monitor for symptoms.</td><td/></tr><tr><td ID="ref10">08/06/2024</td><td>Hypercholesterolemia (ICD-10 - E78.00)</td><td/><td>Low cholesterol / high fiber diet. Monitor. present as a complication of diabetes </td><td/></tr><tr><td ID="ref11">08/06/2024</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td/><td>If you smoke, quit.  Also avoid air pollution, chemical fumes, dust, and secondhand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.</td><td/></tr><tr><td ID="ref12">08/06/2024</td><td>Simple chronic bronchitis (ICD-10 - J41.0)</td><td/><td>If you smoke, quit. Also avoid air pollution, chemical fumes, dust, and second hand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.</td><td/></tr><tr><td ID="ref13">08/06/2024</td><td>History of hepatitis C (ICD-10 - Z86.19)</td><td/><td>Monitor for now. Follow-up.</td><td/></tr><tr><td ID="ref14">08/06/2024</td><td>Primary osteoarthritis involving multiple joints (ICD-10 - M15.9)</td><td/><td>Stay active. Exercise can keep your joints flexible and build stronger muscles to protect and support joints affected by arthritis. Maintaining a healthy weight also relieves stress on painful joints. Monitor symptoms.</td><td/></tr><tr><td ID="ref15">08/06/2024</td><td>Chronic pain syndrome (ICD-10 - G89.4)</td><td/><td>The patient meets established guidelines for the management of non-malignant pain. Discussed the risks, benefits, and side effects of medication treatment including but not limited to medication abuse, tolerance, sedation, addiction and dependence. The PDMP (Eforsce) and random drug screenings are monitored for compliance. Current therapy improved the patient's functional capacity and quality of life.</td><td/></tr><tr><td ID="ref16">08/06/2024</td><td>OPIOID DEPENDENCE, CONTINUOUS (ICD-10 - F11.20)</td><td/><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high-risk situations; Use has resulted in a reduction of recreational, social and/or occupational activities; Note: Physical dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.</td><td/></tr><tr><td ID="ref17">08/06/2024</td><td>BPH loc w urin obs/LUTS (ICD-10 - N40.1)</td><td/><td>Mild symptoms can be decreased by reducing you liquid intake, avoiding caffeine and alcohol and by preventing constipation. Monitor symptoms.satarend PSA levels </td><td/></tr><tr><td ID="ref18">08/06/2024</td><td>Drug-induced constipation (ICD-10 - K59.03)</td><td/><td>daily  stool softener - as long as on chroinc pain meds.  Incrase water in diet </td><td/></tr><tr><td ID="ref19">08/06/2024</td><td>Morbid obesity (ICD-10 - E66.01)</td><td/><td>Linked to BP, LIPID, OA .Knows weight reduction is a priority issue. Monitor weights.</td><td/></tr><tr><td ID="ref20">08/06/2024</td><td>Right knee pain, unspecified chronicity (ICD-10 - M25.561)</td><td/><td>elevate, ice, steroid pack. Xray . Possible cortisone shot </td><td/></tr><tr><td ID="ref21">08/06/2024</td><td>BMI 37.0-37.9, adult (ICD-10 - Z68.37)</td><td/><td>Make sure you are staying well hydrated with enough water. Try to avoid all sugary drinks such as sodas, fruit juices, and sport drinks. Eliminate junk food. Watch your carbs.</td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Albuterol Sulfate (2.5 MG/3ML) 0.083%</td><td>USE 3 ML VIA NEBULIZER EVERY 6 HOURS Inhalation every 6 hrs for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Cefdinir 300 MG</td><td>1 capsule Orally twice a day for 10 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td>Adjust therapy to improve A1C - follow-up to monitorA1C, GFR and urine proteins - CKD2 present as a complication of diabetes. Adjust therapy to improve A1C - follow-up to monitorA1C, GFR and urine proteins - CKD2 present as a complication of diabetes.</td></tr><tr><td ID="instructionpot2">Type 2 diabetes mellitus with diabetic polyneuropathy</td><td>Monitor neurologic signs and symptoms going forward- neuropathy present as a complication of diabetes</td></tr><tr><td ID="instructionpot3">Long term (current) use of insulin</td><td>Adjust therapy to improve A1C - follow-up to monitorA1C. Adjust therapy to improve A1C - follow-up to monitorA1C.</td></tr><tr><td ID="instructionpot4">Type 2 diabetes mellitus with other diabetic kidney complication</td><td>follow-up to monitorA1C, GFR and urine proteins - proteinuria present as a complication of diabetes.</td></tr><tr><td ID="instructionpot5">Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</td><td>Monitor vascular signs and symptoms going forward- PVD present as a complication of diabetes</td></tr><tr><td ID="instructionpot6">Chronic kidney disease, stage 2 (mild)</td><td>In order to preserve renal function we need strict control of blood pressure - which should be less than 140/90 per JNC-8 guidelines; strict control of the LDL cholesterol which should be below 100, using statins if necessary. I encourage you to drink 50 ounces of fluids daily, and follow a low sodium diet. Avoid nephrotoxins (like NSAIDs). Monitor.</td></tr><tr><td ID="instructionpot7">Proteinuria, unspecified</td><td>monitorA1C, GFR and urine proteins - proteinuria present as a complication of diabetes.</td></tr><tr><td ID="instructionpot8">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td>Controlling your high blood pressure is a lifelong commitment.  You will always need to monitor your weight, make healthy food choices, exercise, learn to cope with stress, avoid smoking, and limit your alcohol intake.  We will monitor your blood pressure going forward.</td></tr><tr><td ID="instructionpot9">Coronary artery disease of native artery of native heart with stable angina pectoris</td><td>Maintain good control of BP and Lipids, Monitor for symptoms.</td></tr><tr><td ID="instructionpot10">Hypercholesterolemia</td><td>Low cholesterol / high fiber diet. Monitor. present as a complication of diabetes </td></tr><tr><td ID="instructionpot11">Chronic obstructive pulmonary disease, unspecified COPD type</td><td>If you smoke, quit.  Also avoid air pollution, chemical fumes, dust, and secondhand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.</td></tr><tr><td ID="instructionpot12">Simple chronic bronchitis</td><td>If you smoke, quit. Also avoid air pollution, chemical fumes, dust, and second hand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.</td></tr><tr><td ID="instructionpot13">History of hepatitis C</td><td>Monitor for now. Follow-up.</td></tr><tr><td ID="instructionpot14">Primary osteoarthritis involving multiple joints</td><td>Stay active. Exercise can keep your joints flexible and build stronger muscles to protect and support joints affected by arthritis. Maintaining a healthy weight also relieves stress on painful joints. Monitor symptoms.</td></tr><tr><td ID="instructionpot15">Chronic pain syndrome</td><td>The patient meets established guidelines for the management of non-malignant pain. Discussed the risks, benefits, and side effects of medication treatment including but not limited to medication abuse, tolerance, sedation, addiction and dependence. The PDMP (Eforsce) and random drug screenings are monitored for compliance. Current therapy improved the patient's functional capacity and quality of life.</td></tr><tr><td ID="instructionpot16">OPIOID DEPENDENCE, CONTINUOUS</td><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high-risk situations; Use has resulted in a reduction of recreational, social and/or occupational activities; Note: Physical dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.</td></tr><tr><td ID="instructionpot17">BPH loc w urin obs/LUTS</td><td>Mild symptoms can be decreased by reducing you liquid intake, avoiding caffeine and alcohol and by preventing constipation. Monitor symptoms.satarend PSA levels </td></tr><tr><td ID="instructionpot18">Drug-induced constipation</td><td>daily  stool softener - as long as on chroinc pain meds.  Incrase water in diet </td></tr><tr><td ID="instructionpot19">Morbid obesity</td><td>Linked to BP, LIPID, OA .Knows weight reduction is a priority issue. Monitor weights.</td></tr><tr><td ID="instructionpot20">Right knee pain, unspecified chronicity</td><td>elevate, ice, steroid pack. Xray . Possible cortisone shot </td></tr><tr><td ID="instructionpot21">BMI 37.0-37.9, adult</td><td>Make sure you are staying well hydrated with enough water. Try to avoid all sugary drinks such as sodas, fruit juices, and sport drinks. Eliminate junk food. Watch your carbs.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:Rodger Rothenberger, 10/03/2024 08:45:00 AM, 13305 N 56TH ST, TAMPA, FL, 33617-1161, 813-988-1101</td></tr><tr><td ID="futureAppt2">Provider Name:Rodger Rothenberger, 10/10/2024 08:30:00 AM, 13305 N 56TH ST, TAMPA, FL, 33617-1161, 813-988-1101</td></tr><tr><td ID="futureAppt3">Provider Name:Rodger Rothenberger, 10/17/2024 01:00:00 PM, 13305 N 56TH ST, TAMPA, FL, 33617-1161, 813-988-1101</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>ACOSTA, Samuel <span class="bold">DOB:</span> 07/29/1964 (60 yo M) <span class="bold">Acc No.</span> 243063 <span class="bold">DOS:</span> 08/06/2024</content></td></tr></thead><tbody><tr><td>UNLOCKED PROGRESS NOTE</td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>ACOSTA, Samuel<br/><span class="bold">Account Number: </span>243063</td><td align="right"><span class="bold">Provider: </span>Rodger Rothenberger, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>07/29/1964<span class="bold">   Age: </span>60 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>08/06/2024</td></tr><tr><td><span class="bold">Phone: </span>813-847-6479</td></tr><tr><td colspan="2"><span class="bold">Address: </span>2900 UNIVERSITY SQUARE DR, APT 24, TAMPA, FL-33612-5554</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. 4 month. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Migrated HPI</span>: <br/>       Today : 58 yo male here to review  ongoing medical therapy for <span class="bold">CAD S/P MI/STENT 2013, IDDM, HYPERTENSION, HYPERCHOLESTEROLEMIA, COPD/ASTHMA, HEPATITIS C, OSTEOARTHRITIS, CHRONIC PAIN SYNDROME</span>. <br/><br/>He just saw Endocrinologist after fasting labs (no results available, but states A1C was "8.0"). TRESIBA 52U AM. FIASP SLIDING SCALE, OZEMPIC WEEKLY. <br/><br/>Cardiology - LHC (2/2022)-Patent Stents; ECHO (4/2023)-LVEF: 55%.<br/><br/>Gastroenterology - He is dealing with alot of bloating and belching and intermittent rectal bleeding.  He just saw Dr. Prasad- who went over his previous Hep C-, but is no longer doing Colonoscopies. He will contact Dr. Mompi for Colonoscopy. No abdominal pain.  Senekot-S every other day.<br/><br/>LBP fluctuating.  Having issues tolerating GABAPENTIN during the day secondary to fatigue.  Pain rx PRN - through pain management.  <br/><br/>MAY: presents with acute pain right knee such that ambulation is difficult. No trauma. He could not take the Medrol Dosepack as his sugar went over 300.  <br/><br/><span class="bold">Med: ASA/PLAVIX, TRESIBA 52U, FIASP SLIDING SCALE, OZEMPIC WEEKLY, LISINOPRIL 5MG, ATORVASTATIN 20MG, VENTOLIN HFA, ALBUTEROL NEB PRN, GABAPENTIN 100MG TID, OXYCODONE 30MG TID.</span><br/><br/>Labs 5/3/23:  BUN/CR=13/1.12;L BS=117; A1C=8.3; MICROALBUMIN-POSITIVE; CBC,LYTES,LFT,TSH,UA-WNL; PSA=0.5; CHOL=227; HDL=44; LDL=163; TRIG=112;  12/15/22:  BUN/CR=19/1.25; BS=202; A1C=9.0; MICROALBUMIN-POSITIVE; CBC,LYTES,LFT-WNL; PSA=0.5; CHOL=243; HDL=46; LDL=179; TRIG=100.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> CAD--RCA STENT--7/2013----NON-Q WAVE MI - (Dr. Feliz)  LHC-2/2022- Patent stents;   ECHO-4/2023- LVEF:55%, HYPERTENSION, IDDM, COPD / ASTHMA, HEPATITIS C, OSTEOARTHRITIS / CHRONIC PAIN SYNDROME, ANXIETY.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Unknown Aspir-Low 81 MG Tablet Delayed Release 1 tablet Orally Once a day , Unknown Atorvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day , Unknown BD Ultra -Fine 111 Short Pen Needles Needles 1 Needle Dermally three times day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*, Unknown Gabapentin 100 MG Capsule 1 capsule Orally Three times per day , Unknown Lantus 100 units/mL solution 52 units one time in the morning subcutaneously Daily , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*, Unknown Lisinopril 5 mg tablet 1 tab(s) orally once a day , Unknown Nebulizer - Device as directed Inhaler as directed , Unknown NovoLOG FlexPen 100 units/mL solution use sliding scale subcutaneously three times a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*, Unknown Omeprazole 40 MG Capsule Delayed Release TAKE ONE CAPSULE BY MOUTH 30 MINUTES BEFORE MORNING MEAL EVERY DAY   , Unknown oxyCODONE HCl 30 MG Tablet 1 tablet Orally four times a day , Unknown Sildenafil Citrate 100 MG Tablet 1 tablet as needed Orally Once a day , Unknown Ventolin HFA CFC free 90 mcg/inh aerosol inhale 2 puffs by mouth 4 times a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Dexcom G6 Device Glucose Monitor Adhesive, Dexcom G6 Device Glucose Monitor Adhesive. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> <br/></td></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22 (Primary)   2. Type 2 diabetes mellitus with diabetic polyneuropathy - E11.42   3. Long term (current) use of insulin - Z79.4   4. Type 2 diabetes mellitus with other diabetic kidney complication - E11.29   5. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene - E11.51   <content><span class="bold">Notes : </span>Decreased peripheral pulses. No clinical symptoms. Monitoring.</content>   6. Chronic kidney disease, stage 2 (mild) - N18.2   7. Proteinuria, unspecified - R80.9   8. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I12.9   9. Coronary artery disease of native artery of native heart with stable angina pectoris - I25.118   10. Hypercholesterolemia - E78.00   11. Chronic obstructive pulmonary disease, unspecified COPD type - J44.9   12. Simple chronic bronchitis - J41.0   13. History of hepatitis C - Z86.19   14. Primary osteoarthritis involving multiple joints - M15.9   15. Chronic pain syndrome - G89.4   16. OPIOID DEPENDENCE, CONTINUOUS - F11.20   17. BPH loc w urin obs/LUTS - N40.1   18. Drug-induced constipation - K59.03   19. Morbid obesity - E66.01   20. Right knee pain, unspecified chronicity - M25.561   21. BMI 37.0-37.9, adult - Z68.37   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Notes: Adjust therapy to improve A1C - follow-up to monitorA1C, GFR and urine proteins - CKD2 present as a complication of diabetes. Adjust therapy to improve A1C - follow-up to monitorA1C, GFR and urine proteins - CKD2 present as a complication of diabetes.  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Type 2 diabetes mellitus with diabetic polyneuropathy</span> <br/>Notes: Monitor neurologic signs and symptoms going forward- neuropathy present as a complication of diabetes  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Long term (current) use of insulin</span> <br/>Notes: Adjust therapy to improve A1C - follow-up to monitorA1C. Adjust therapy to improve A1C - follow-up to monitorA1C.  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Type 2 diabetes mellitus with other diabetic kidney complication</span> <br/>Notes: follow-up to monitorA1C, GFR and urine proteins - proteinuria present as a complication of diabetes.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</span> <br/>Notes: Monitor vascular signs and symptoms going forward- PVD present as a complication of diabetes  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Chronic kidney disease, stage 2 (mild)</span> <br/>Notes: In order to preserve renal function we need strict control of blood pressure - which should be less than 140/90 per JNC-8 guidelines; strict control of the LDL cholesterol which should be below 100, using statins if necessary. I encourage you to drink 50 ounces of fluids daily, and follow a low sodium diet. Avoid nephrotoxins (like NSAIDs). Monitor.  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Proteinuria, unspecified</span> <br/>Notes: monitorA1C, GFR and urine proteins - proteinuria present as a complication of diabetes.  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Notes: Controlling your high blood pressure is a lifelong commitment.  You will always need to monitor your weight, make healthy food choices, exercise, learn to cope with stress, avoid smoking, and limit your alcohol intake.  We will monitor your blood pressure going forward.  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Coronary artery disease of native artery of native heart with stable angina pectoris</span> <br/>Notes: Maintain good control of BP and Lipids, Monitor for symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Hypercholesterolemia</span> <br/>Notes: Low cholesterol / high fiber diet. Monitor. present as a complication of diabetes   </td></tr><tr><td/></tr><tr><td><span class="bold">11. Chronic obstructive pulmonary disease, unspecified COPD type</span> <br/>Notes: If you smoke, quit.  Also avoid air pollution, chemical fumes, dust, and secondhand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Simple chronic bronchitis</span> <br/>Start Cefdinir Capsule, 300 MG, 1 capsule, Orally, twice a day, 10 days, 20, Refills 3; Refill Albuterol Sulfate Nebulization Solution, (2.5 MG/3ML) 0.083%, USE 3 ML VIA NEBULIZER EVERY 6 HOURS, Inhalation, every 6 hrs, 30 days, 120, Refills 11.  <br/>Notes: If you smoke, quit. Also avoid air pollution, chemical fumes, dust, and second hand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.  </td></tr><tr><td/></tr><tr><td><span class="bold">13. History of hepatitis C</span> <br/>Notes: Monitor for now. Follow-up.  </td></tr><tr><td/></tr><tr><td><span class="bold">14. Primary osteoarthritis involving multiple joints</span> <br/>Notes: Stay active. Exercise can keep your joints flexible and build stronger muscles to protect and support joints affected by arthritis. Maintaining a healthy weight also relieves stress on painful joints. Monitor symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">15. Chronic pain syndrome</span> <br/>Notes: The patient meets established guidelines for the management of non-malignant pain. Discussed the risks, benefits, and side effects of medication treatment including but not limited to medication abuse, tolerance, sedation, addiction and dependence. The PDMP (Eforsce) and random drug screenings are monitored for compliance. Current therapy improved the patient's functional capacity and quality of life.  </td></tr><tr><td/></tr><tr><td><span class="bold">16. OPIOID DEPENDENCE, CONTINUOUS</span> <br/>Notes: Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high-risk situations; Use has resulted in a reduction of recreational, social and/or occupational activities; Note: Physical dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.  </td></tr><tr><td/></tr><tr><td><span class="bold">17. BPH loc w urin obs/LUTS</span> <br/>Notes: Mild symptoms can be decreased by reducing you liquid intake, avoiding caffeine and alcohol and by preventing constipation. Monitor symptoms.satarend PSA levels   </td></tr><tr><td/></tr><tr><td><span class="bold">18. Drug-induced constipation</span> <br/>Notes: daily  stool softener - as long as on chroinc pain meds.  Incrase water in diet   </td></tr><tr><td/></tr><tr><td><span class="bold">19. Morbid obesity</span> <br/>Notes: Linked to BP, LIPID, OA .Knows weight reduction is a priority issue. Monitor weights.  </td></tr><tr><td/></tr><tr><td><span class="bold">20. Right knee pain, unspecified chronicity</span> <br/>Notes: elevate, ice, steroid pack. Xray . Possible cortisone shot   </td></tr><tr><td/></tr><tr><td><span class="bold">21. BMI 37.0-37.9, adult</span> <br/>Notes: Make sure you are staying well hydrated with enough water. Try to avoid all sugary drinks such as sodas, fruit juices, and sport drinks. Eliminate junk food. Watch your carbs.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronic signature of Rodger Rothenberger , MD, ME136062  on 09/10/2024 at 05:24 PM EDT</td></tr><tr><td valign="top">Sign off status: Pending</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span"/></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Rodger Rothenberger, MD</td><td align="right"><span class="bold">Date: </span>08/06/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 09/10/2024 05:24 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/></body></html>